Another rights issue15 Jul 2020 17:01
"Futura, a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal Dermasys® drug delivery technology and focused on sexual health and pain confirms that, further to the announcement made on Friday, it has conditionally raised £3.25 million in aggregate before fees and expenses through a successful Subscription and PrimaryBid Offer at the Issue Price of 8 pence per share. "
[RNS, 23rd Dec 2019]
Totally missed that 'placing'? I was right (yet again!!), that last 'placing' (RI) was for 8p per share. The Eagle swoops again!!